This report examines which US states allow the sale of intoxicating hemp-derived cannabinoid (IHDC) products in licensed dispensaries and which states have dispensaries offering them – regardless of whether they are permitted – to demonstrate the states that effectively deter IHDC sales in dispensaries
This regulatory report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy
This report covers, state by state, the widely differing tax policies for medical cannabis in the US
This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products
This report covers, state by state, the question of whether each US state allows the sale of hemp-derived CBD vaping products and on what legal terms
This report examines US federal and all state law as it pertains to CBD in pet food
This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states’ regulations as possible
Cosmetics have been a mainstay in the CBD market in the US, and there are no signs that is likely to change any time soon. This report offers an overview of the current status of CBD in cosmetics in each US state
This report takes a state-by-state look at the status of CBD in foods in the US, detailing the current framework and status
With the federal legalisation of hemp in the US , states were left to enact their own legislation to adapt. CBD-Intel provides an overview of US law on smokable hemp, along with analysis of each state’s rules
In Utah, different permits are required for the purpose of growing, cultivating, processing, or marketing industrial hemp or an industrial hemp product. This snapshot provides regulatory information around a number of aspects regarding CBD